NAFLD prevalence nears 40% in Aussie study
The prevalence of non-alcoholic fatty liver disease has risen to nearly 40% as rates of obesity and takeaway food consumption grow in tandem, Australian researchers…
Tag: Obesity
Metformin has ‘clear metabolic benefits’ in PCOS, review finds
Metformin has clear benefits for women with PCOS and should be considered for those with overweight or obesity to improve weight loss, insulin resistance and…
Semaglutide benefits for HFpEF ‘largest seen with any agent’, researchers claim
Semaglutide may be a new therapeutic option for obesity-related heart failure with preserved ejection fraction, with results from a landmark study showing substantial reductions in…
PBAC plan to restrict diabetes drug prescribing ‘inconsistent with guidelines’
A proposed PBS crackdown on GLP-1 receptor agonists is inconsistent with type 2 diabetes management guidelines and will force doctors to prescribe less efficacious drugs,…
Obesity is a disease – but should its name be changed?
The clinical debate on the status of obesity as a disease has been protracted. But in the last decade, medical organisations around the globe from…
Gastric bypass tied to substance use disorder
Gastric bypass surgery is associated with an increased risk for non-alcohol substance use disorder, according to a study in Obesity. Dr Per-Arne Svensson (PhD), from…
Only 1 in 10 patients achieve 5% weight loss in a year: study
Just one in 10 adults with overweight or obesity are likely to achieve clinically meaningful weight loss in a year, a US study shows. But…
Excess belly fat may hamper effectiveness of IBD meds: study
Patients with higher levels of intra-abdominal visceral fat are less likely to achieve improvements from biologic treatments for inflammatory bowel disease, a US study shows.…
PBAC to consider semaglutide listing for weight loss
Novo Nordisk has applied for PBS funding for its subcutaneous weight loss drug Wegovy as a severe obesity treatment. The product contains the GLP-1 receptor…
Trying to lose weight? Let your loved one be your semaglutide
An overweight man with high blood pressure asked me about Ozempic (semaglutide) the other day, but said it would be difficult for him to afford.…
